HEALTH OF WOMAN. 2019.4(140): 55–58; doi 10.15574/HW.2019.140.55

Leush S. St., Ventskivs’ka I. B., Zahorodnia O. S.
National medical university by name of O.O. Bogomolets

The article presents the results of a prospective study on the presence of antiphospholipid antibodies in healthy primagravida with the analysis of further gestational complications.
The objective: to determine the serum circulation of antibodies to different types of phospholipids in the first and second gestational trimester and to study the incidence of obstetric complications depending on this circulation.
Materials and methods. Determination of antibodies to phospholipids in 11–12 and 18–20 gestational weeks by immunoassay analysis. The study included 150 primagravida (11-12 weeks) without reproductive impairment in history, a re-study was performed in 148 women, since 2 cases of spontaneus abortion were observed. The relative risk of development of major obstetric complications in women with the appearance of antibodies to phospholipids in the second trimester of pregnancy is calculated.
Results. At the first inspection, the frequency of detection of antibodies to phospholipids ranged from 3 to 4%, which corresponds to global data on the prevalence of antibody circulation in a healthy population. However, in 18-20 weeks, a statistically significant increase in the frequency of antibody circulation, mainly to phosphatidylserine (21.6%) and phosphatidylethanolamine (17.4%), was detected. The peculiarities of the structure of the cell membrane are asymmetry of the location of phospholipids, in which negatively charged molecules, including phosphatidylserine and phosphotadylethanolamine, are located dominantly in a inner layer. The emergence of antibodies precisely to these molecules in the dynamics of pregnancy is evidence of their externalization, which may be the result of a violation of the normal functioning of the endothelium. Analysis of the course of the second half of pregnancy in patients with detected antibody subtypes showed an increase in the relative risk of severe preeclampsia, placental dysfunction and premature labor.
Conclusions: 1. The APA circulation frequency by healthy primagravida in first gestational trimester is in accordance to world population. 2. In the second trimester an increasing of APA detection is registered, exactly for phosphatidylserin (21.6%) and phosphatidyletanolamin (17.4%) antibodies 3. Appearance of antibodies to negative phospholipids in the second pregnancy trimester lets propose destabilization of endothelium membranes in these patients, what is confirmed by a higher frequency of main obstetrics complications prospectively.
Key words: antibodies to phospholipids, phosphatidylserine antibodies, phosphatidylethanolamine antibodies, endothelial dysfunction.

REFERENCES

Zagorodnia OS. 2014. Vplyv antyfosfolipdinoho syndromu na perebih polohiv. Ukrainskyi zhurnal klinichnoi ta laboratornoi medytsyny 4: 23–27.

Bobba R, Johnson S, Davis A. 2007. A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? J Rheumatol. 34 (7): 1522-7.

Costedoat-Chalumeau N, Leguern V, Leroux G et al. 2012. Pregnancy and antiphospholipid syndrome. Rev Med Interne. 33 (4): 209-16. https://doi.org/10.1016/j.revmed.2012.01.003; PMid:22341691

Devaux P. 1992. Protein involvement in transmembrane lipid asymmetry. Ann. Rev. Biophys. Biomol. Struct. 21: 417–439. https://doi.org/10.1146/annurev.bb.21.060192.002221; PMid:1525472

Duarte-Garcia A, Pham M, Crowson C et al. 2017. Epidemiology of Antiphospholipid Syndrome: A Population-Based Study. Arthritis Rheumatol. 69:34–45.

McNeil H, Chesterman C, Krilis S. 1991. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49: 193–280. https://doi.org/10.1016/S0065-2776(08)60777-4

Mulla M, Brosens J, Chamley L et al. 2009. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol. 62 (2): 96–111. https://doi.org/10.1111/j.1600-0897.2009.00717.x; PMid:19614626 PMCid:PMC2772057

Park S, Jang S, Park C, Chi H. 2016. Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful? Biomed Res Int. 16: 64–75. https://doi.org/10.1155/2016/2641526; PMid:27610369 PMCid:PMC5005572

Pengo V, Ruffatti A, Del Ross T et al. 2013. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. J Thromb Haemost. 11 (8): 1527-31. https://doi.org/10.1111/jth.12264; PMid:23601766.

Schroit A, Zwaal R. 1991. Transbilayer movement of phospholipids in red cell and platelet membrane. Biochem. Biophys. Acta. 1071: 313–329. https://doi.org/10.1016/0304-4157(91)90019-S